New, Novel Lipid-Lowering Agents for Reducing Cardiovascular Risk: Beyond Statins

Mostrar otras versiones (1)

Statins are the cornerstone of the prevention and treatment of atherosclerotic cardiovascular disease (ASCVD). However, even under optimal statin therapy, a significant residual ASCVD risk remains. Therefore, there has been an unmet clinical need for novel lipid-lowering agents that can target low-d...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Kyuho, Ginsberg, Henry N., Choi, Sung Hee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Diabetes Association 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9353557/
https://www.ncbi.nlm.nih.gov/pubmed/35929170
http://dx.doi.org/10.4093/dmj.2022.0198

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9353557/
https://www.ncbi.nlm.nih.gov/pubmed/35929170
http://dx.doi.org/10.4093/dmj.2022.0198

Ejemplares similares